Search Results - "Fitzpatrick, Martin A"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Robust, Sensitive, and Automated Phosphopeptide Enrichment Optimized for Low Sample Amounts Applied to Primary Hippocampal Neurons by Post, Harm, Penning, Renske, Fitzpatrick, Martin A, Garrigues, Luc B, Wu, W, MacGillavry, Harold D, Hoogenraad, Casper C, Heck, Albert J. R, Altelaar, A. F. Maarten

    Published in Journal of proteome research (03-02-2017)
    “…Because of the low stoichiometry of protein phosphorylation, targeted enrichment prior to LC–MS/MS analysis is still essential. The trend in phosphoproteome…”
    Get full text
    Journal Article
  2. 2

    Metabolomics--a novel window into inflammatory disease by Fitzpatrick, Martin, Young, Stephen P

    Published in Swiss medical weekly (21-01-2013)
    “…Inflammation is an important component of normal responses to infection and injury. However, chronic activation of the immune system, due to aberrant responses…”
    Get full text
    Journal Article
  3. 3

    Pathomx: an interactive workflow-based tool for the analysis of metabolomic data by Fitzpatrick, Martin A, McGrath, Catherine M, Young, Stephen P

    Published in BMC bioinformatics (10-12-2014)
    “…Metabolomics is a systems approach to the analysis of cellular processes through small-molecule metabolite profiling. Standardisation of sample handling and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Metabolic Profiling Predicts Response to Anti–Tumor Necrosis Factor α Therapy in Patients With Rheumatoid Arthritis by Kapoor, Sabrina R., Filer, Andrew, Fitzpatrick, Martin A., Fisher, Benjamin A., Taylor, Peter C., Buckley, Christopher D., McInnes, Iain B., Raza, Karim, Young, Stephen P.

    Published in Arthritis and rheumatism (01-06-2013)
    “…Objective Anti–tumor necrosis factor (anti‐TNF) therapies are highly effective in rheumatoid arthritis (RA) and psoriatic arthritis (PsA), but a significant…”
    Get full text
    Journal Article
  6. 6

    Metabolic Profiling Predicts Response to Anti-Tumor Necrosis Factor [alpha] Therapy in Patients With Rheumatoid Arthritis by Kapoor, Sabrina R, Filer, Andrew, Fitzpatrick, Martin A, Fisher, Benjamin A, Taylor, Peter C, Buckley, Christopher D, McInnes, Iain B, Raza, Karim, Young, Stephen P

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-06-2013)
    “…Objective Anti-tumor necrosis factor (anti-TNF) therapies are highly effective in rheumatoid arthritis (RA) and psoriatic arthritis (PsA), but a significant…”
    Get full text
    Journal Article